These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide. Lin Y, Waer M. Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224 [No Abstract] [Full Text] [Related]
5. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection. Sakurai Y, Kagawa K, Kato Y, Otani H, Nonoyama A. Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433 [No Abstract] [Full Text] [Related]
9. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
10. Modified graft rejection by transfusion of the donor: a role for dendritic cells. Heineman E, Bouwman E, Marquet RL, Jeekel J. Transplant Proc; 1987 Feb; 19(1 Pt 2):1470-2. PubMed ID: 3274358 [No Abstract] [Full Text] [Related]
11. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK, Lemström KB, Häyry PJ. Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [Abstract] [Full Text] [Related]
12. Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine. Brunson ME, Tchervenkov JI, Alexander JW, Cofer BR. Transplant Proc; 1991 Feb; 23(1 Pt 1):307-8. PubMed ID: 1990538 [No Abstract] [Full Text] [Related]
14. Treatment strategies of hamster-to-rat cardiac xenotransplantation. Steinbrüchel DA, Nielsen B, Kemp E. Transplant Proc; 1994 Apr; 26(2):1039-41. PubMed ID: 8171460 [No Abstract] [Full Text] [Related]
15. Effect of steroids on cellular proliferation in rat cardiac allografts. Ruers TJ, Buurman W, Kootstra G. Transplant Proc; 1991 Feb; 23(1 Pt 1):488. PubMed ID: 1990594 [No Abstract] [Full Text] [Related]
16. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation. Hisatomi K, Isomura T, Matsuzoe S, Satou T, Hirano A, Kohjiro M. Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960 [No Abstract] [Full Text] [Related]
17. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW. Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348 [No Abstract] [Full Text] [Related]
18. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. Candinas D, Achilleos O, Lee SJ, Dalgic A, Mayer AD, Buckels JA, McMaster P, D'Silva M. Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959 [No Abstract] [Full Text] [Related]
19. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. Hara Y, Matsuura T, Imanishi M, Tahara H, Kurita T. Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955 [No Abstract] [Full Text] [Related]
20. Tempo of induction of W3/25+ suppressor cells in cyclosporine-treated rat cardiac allograft recipients. Hall BM, Gurley KE, Dorsch SE. Transplant Proc; 1987 Feb; 19(1 Pt 1):504. PubMed ID: 2978917 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]